Loading...
NeueHealth Q1 2025 Earnings Report
NeueHealth reported strong first quarter performance with significant growth in consumers served and positive Adjusted EBITDA.
Key Takeaways
NeueHealth, a value-driven healthcare company, reported strong first quarter 2025 financial results, including a total revenue of $215.787 million and a net loss of $10.848 million. The company achieved positive Adjusted EBITDA for the fifth consecutive quarter and saw a 51% increase in consumers served compared to the first quarter of 2024.
Total revenue for Q1 2025 was $215.787 million, compared to $245.095 million in Q1 2024.
Net loss for Q1 2025 was $10.848 million, compared to a net loss of $4.177 million in Q1 2024.
Adjusted EBITDA was $13.478 million, marking the fifth consecutive quarter of positive Adjusted EBITDA.
The company served approximately 709,000 consumers, representing a 51% increase over the first quarter of 2024.
NeueHealth
NeueHealth
NeueHealth Revenue by Segment
Revenue by Segment
NeueCare Revenue
CapyFin.comNeueSolutions Revenue
CapyFin.com Forward Guidance
NeueHealth is focused on driving long-term, sustainable growth and building on industry relationships in 2025 and beyond, leveraging its value-driven, consumer-centric care model.
Positive Outlook
- Continued resonance of the value-driven, consumer-centric care model in the market.
- Focus on driving long-term, sustainable growth.
- Building on established relationships across the healthcare industry.
- Alignment of interests among health consumers, providers, and payors.
- Commitment to creating a seamless, more coordinated care experience.
Challenges Ahead
- Potential litigation relating to the Transaction.
- Risk of stock price decline if the Transaction is not consummated.
- Restrictions during the pendency of the Transaction impacting business opportunities.
- Costs associated with the Transaction.
- Uncertainty regarding the ability to obtain short or long-term debt or equity financing.